Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies
The Internet Journal of Pulmonary Medicine · 2003
DOI: 10.5580/1131 ↗At a glance
Journal article in The Internet Journal of Pulmonary Medicine, 2003.
Abstract (original language)
We report the first case of myeloid metaplasia with myelofibrosis (MMM) associated with antiphospholipid syndrome (APS) causing pulmonary arterial hypertension (PAH) and coagulation factor V deficiency. Chronic thromboembolic distal PAH occurs in the context of MMM and APS. These procoagulant states may independently involve the arterial and venous system. Therefore, recurrent thromboembolism in thrombophilia associated with MMM and APS may coexist in the development of PH and coagulation factor deficiencies. Abbreviations: MMM: Myeloid Metaplasia with Myelofibrosis; Antiphospholipid Syndrome: APS; Pulmonary Arterial Hypertension: PAH; Myeloproliferative Disorders: MPD.
Cite
APA
(2003). Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies. The Internet Journal of Pulmonary Medicine. https://doi.org/10.5580/1131
Vancouver
Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies. The Internet Journal of Pulmonary Medicine. 2003. doi:10.5580/1131
BibTeX
@article{euvimed2003,
title = {Myelofibrosis With Myeloid Metaplasia And Antiphospholipid Syndrome: Coexistent Etiologies Of Pulmonary Hypertension And Coagulation Factor Ii And V Deficiencies},
journal = {The Internet Journal of Pulmonary Medicine},
year = {2003},
doi = {10.5580/1131}
}
EUVIMED